Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Piramal Pharma Community
NSEI:PPLPHARMA Community
1
Narratives
written by author
0
Comments
on narratives written by author
10
Fair Values set
on narratives written by author
Community Investing Ideas
Piramal Pharma
Popular
Undervalued
Overvalued
Piramal Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Expanding Capacity Will Capture Global Healthcare Demand
Key Takeaways Expansion in manufacturing and differentiated offerings leverages rising global healthcare demand and outsourcing trends, supporting strong revenue growth and improved profitability. Enhanced regulatory compliance and focus on high-margin, specialty products reduce operational risks and margin volatility while strengthening competitive positioning.
View narrative
₹256.67
FV
26.0% undervalued
intrinsic discount
13.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
PPLPHARMA
PPLPHARMA
Piramal Pharma
Your Fair Value
₹
Current Price
₹189.94
1.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-2b
161b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹160.7b
Earnings ₹1.7b
Advanced
Set Fair Value